Applied DNA Sciences Inc. (APDN)
| Bid | 2 |
| Market Cap | 1.96M |
| Revenue (ttm) | 130.86K |
| Net Income (ttm) | -298.6K |
| EPS (ttm) | -32.5 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -0.18 |
| Analyst | Buy |
| Ask | 2.03 |
| Volume | 2,193,545 |
| Avg. Volume (20D) | 519,858 |
| Open | 1.85 |
| Previous Close | 1.93 |
| Day's Range | 1.69 - 1.90 |
| 52-Week Range | 1.67 - 510.00 |
| Beta | 0.42 |
About APDN
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection ...
Analyst Forecast
According to 1 analyst ratings, the average rating for APDN stock is "Buy." The 12-month stock price forecast is $75, which is an increase of 4125.35% from the latest price.
Stock Forecasts
1 week ago · accessnewswire.com
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effec...
1 month ago · seekingalpha.com
Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call TranscriptApplied DNA Sciences, Inc. (NASDAQ:APDN ) Q1 2025 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Sanjay Hurry - Executive Director, IR & Corporate Communications Beth Jantz...
1 month ago · accessnewswire.com
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it...